Quotes 5-day view Delayed Swiss Exchange
08/03/2022
08/04/2022
08/05/2022
08/08/2022
08/09/2022
Date
72.4(c)
72.6(c)
67.7(c)
69.5(c)
59.85
Last
144 889
99 076
114 401
66 578
303 583
Volume
-1.76%
+0.28%
-6.75%
+2.66%
-13.88%
Change
Estimated financial data (e) CHF USD
Sales 2022
1 743 M
1 829 M
1 829 M
Net income 2022
-169 M
-177 M
-177 M
Net Debt 2022
445 M
467 M
467 M
P/E ratio 2022
-4,34x
Yield 2022
-
Sales 2023
2 235 M
2 344 M
2 344 M
Net income 2023
-126 M
-132 M
-132 M
Net Debt 2023
563 M
590 M
590 M
P/E ratio 2023
-5,89x
Yield 2023
-
Capitalization
724 M
759 M
759 M
EV / Sales 2022
0,67x
EV / Sales 2023
0,58x
Nbr of Employees
2 131
Free-Float
85,3%
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and...
Ratings of Zur Rose Group AG
All news about ZUR ROSE GROUP AG
News in other languages on ZUR ROSE GROUP AG
Analyst Recommendations on ZUR ROSE GROUP AG
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ZUR ROSE GROUP AG
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
69,50 CHF
Average target price
142,45 CHF
Spread / Average Target
105%
Please enable JavaScript in your browser's settings to use dynamic charts.